Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr;1(2):115-125.
doi: 10.1089/crispr.2017.0024.

Do CRISPR Germline Ethics Statements Cut It?

Affiliations

Do CRISPR Germline Ethics Statements Cut It?

Carolyn Brokowski. CRISPR J. 2018 Apr.

Abstract

The extraordinary wave of genomic-engineering innovation, driven by CRISPR-Cas9, has sparked worldwide scientific and ethical uncertainty. Great concern has arisen across the globe about whether heritable genome editing should be permissible in humans-that is, whether it is morally acceptable to modify genomic material such that the "edit" is transferable to future generations. Here I examine 61 ethics statements released by the international community within the past 3 years about this controversial issue and consider the statements' overarching positions and limitations. Despite their inability to fully address all important considerations, many of the statements may advance debate and national and international law and public policy.

PubMed Disclaimer

Conflict of interest statement

No competing financial interests exist.

Figures

<b>FIG. 1.</b>
FIG. 1.
Cover Story: More than 60 official reports and statements about the ethics of germline editing have been published within the past three years.
<b>FIG. 2.</b>
FIG. 2.
Bioethics considerations. Extracts from some selected reports on genome editing illustrate a diversity of opinions on some key bioethical issues.
<b>FIG. 3.</b>
FIG. 3.
Opinions on the moral permissibility of heritable genome editing. This pie chart displays the views of 61 ethics reports on germline editing. The views represented are not logically exhaustive. The majority (54%) expressly considered germline editing impermissible at the current time.,,,,,,,,,,,,,,,,, A further 11% also consider germline editing impermissible currently, but are expressly open to the possibility of allowing it under certain conditions.,,,,,, In 30% of cases, the position is not expressly addressed or is ambiguous.,,,,,,,,,,,,, And 5% of the reports state an openness to further exploration.,,

References

    1. National Academies of Sciences Engineering and Medicine. Human genome editing: science, ethics, and governance. Washington, DC: The National Academies Press (U.S.) 2017 - PubMed
    1. National Academies of Sciences Engineering and Medicine. News. With stringent oversight, heritable germline editing clinical trials could one day be permitted for serious conditions; non-heritable clinical trials should be limited to treating or preventing disease or disability at this time. https://nam.edu/with-stringent-oversight-heritable-germline-editing-clin... (last accessed April14, 2018)
    1. Code of Federal Regulations: Research Involving Pregnant Women or Fetuses, 45 C.F.R. Sect 46 (2017)
    1. United States Code: Institutional Review Boards; Ethics Guidance Program, 42 U.S. Code Sect 289 (2017)
    1. Consolidated Appropriations Act of 2016. www.congress.gov/114/bills/hr2029/BILLS-114hr2029enr.pdf (last accessed April14, 2018)

LinkOut - more resources